# Centene Corp: Form 10-Q for the period ended Jun 30, 2021

- Company: [Centene Corp](/companies/cnc.md) (CIK 1071739)
- Form: 10-Q
- Filed: 2021-07-27
- Accepted by EDGAR: Jul 27, 2021, 01:14 ET
- Period: 2021-06-30
- Accession: 0001071739-21-000183
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1071739/000107173921000183/cnc-20210630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1071739/000107173921000183/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-04-01 to 2021-06-30 | $28.86bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2021-01-01 to 2021-06-30 | $56.98bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2021-04-01 to 2021-06-30 | $1.11bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2021-01-01 to 2021-06-30 | $2.15bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months, 2021-04-01 to 2021-06-30 | $2.27bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months, 2021-01-01 to 2021-06-30 | $4.64bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2021-04-01 to 2021-06-30 | −$418.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2021-01-01 to 2021-06-30 | $636.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-04-01 to 2021-06-30 | $163.0m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2021-01-01 to 2021-06-30 | $333.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-04-01 to 2021-06-30 | −$7.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2021-01-01 to 2021-06-30 | $237.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-04-01 to 2021-06-30 | −$535.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2021-01-01 to 2021-06-30 | $164.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-04-01 to 2021-06-30 | −$0.92 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2021-01-01 to 2021-06-30 | $0.28 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-04-01 to 2021-06-30 | −$0.92 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2021-01-01 to 2021-06-30 | $0.28 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-04-01 to 2021-06-30 | 582,804,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2021-01-01 to 2021-06-30 | 589,799,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2021-01-01 to 2021-06-30 | $1.73bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months, 2021-01-01 to 2021-06-30 | $437.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months, 2021-01-01 to 2021-06-30 | $33.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-06-30 | $11.02bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-06-30 | $25.46bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-06-30 | $71.54bn | us-gaap:Assets |
| Current liabilities | at 2021-06-30 | $23.64bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-06-30 | $45.41bn | us-gaap:Liabilities |
| Long-term debt | at 2021-06-30 | $16.54bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-06-30 | $253.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2021-06-30 | $25.91bn | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1071739/000107173921000183/cnc-20210630.htm

Filed Jul 27, 2021.
Source: SEC EDGAR, the filing index for accession 0001071739-21-000183. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.
